Increased Body Mass Index during Therapy for Childhood Acute Lymphoblastic Leukemia: A Significant and Underestimated Complication

Table 2

Mean BMI -scores at the end of treatment for ALL.

Age at diagnosis	Males			Females
	ALL; mean BMI -score; (95% CI)	Healthy; mean BMI; -score	Difference in mean; BMI -score; (ALL-healthy)	ALL; mean BMI -score (95% CI)	Healthy mean BMI; -score	Difference in mean; BMI -score; (ALL-healthy)
Standard risk
2	1.04 (0.77, 1.32)	0.17	0.88	1.23 (0.86, 1.61)	0.10	1.13
4	0.82 (0.58, 1.06)	0.21	0.61	1.25 (0.95, 1.55)	0.15	1.10
6	0.59 (0.35, 0.84)	0.29	0.31	1.27 (0.93, 1.61)	0.24	1.03
8	0.37 (0.06, 0.68)	0.35	0.02	1.29 (0.83, 1.75)	0.32	0.97
10	0.14 (−0.25, 0.54)	0.37	−0.22	1.31 (0.68, 1.93)	0.38	0.93
High risk
10	0.30 (−0.07, 0.67)	0.37	−0.06	0.45 (−0.03, 0.92)	0.38	0.07
12	0.08 (−0.30, 0.45)	0.34	−0.26	0.47 (0.002, 0.93)	0.40	0.07